Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Total Non-Current Liabilities (2023 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $55.9 million as the latest value for Q3 2025.

  • Quarterly Total Non-Current Liabilities rose 5.19% to $55.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $55.9 million through Sep 2025, up 5.19% year-over-year, with the annual reading at $50.8 million for FY2024, 23.88% up from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $55.9 million at Xtant Medical Holdings, up from $54.9 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $55.9 million in Q3 2025, with the low at $41.0 million in Q4 2023.
  • Average Total Non-Current Liabilities over 3 years is $50.5 million, with a median of $51.4 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities rose 23.88% in 2024, then rose 5.19% in 2025.
  • Over 3 years, Total Non-Current Liabilities stood at $41.0 million in 2023, then grew by 23.88% to $50.8 million in 2024, then increased by 9.93% to $55.9 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $55.9 million, $54.9 million, and $51.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.